Maryland Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 13 (76% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,796
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 53.36%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 402
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 41.74%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 44.43% 35.07%
White, Hispanic/Latino Patients 7.24% 1.24%
Black/African American, Non-Hispanic/Latino Patients 28.45% 13.68%
Black/African American, Hispanic/Latino Patients 0.95% 1.00%
Asian Patients3 1.06% 1.74%
American Indian/Alaska Native Patients3 1.78% 0.25%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00%
Patients with More than one race3 6.85% 5.72%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.51% 1.49%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.84% 5.47%
Unreported/Refused to Report Race and Ethnicity 1.89% 34.33%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 328
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 77.20%
COVID-19 Immunization Series Completed 350
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 82.46%
COVID-19 Immunization Series Additional 68
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 66.67%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 21.34% 17.14% 32.35%
White, Hispanic/Latino Patients 5.49% 4.86% 1.47%
Black/African American, Non-Hispanic/Latino Patients 43.29% 43.43% 47.06%
Black/African American, Hispanic/Latino Patients 4.27% 7.14% 1.47%
Asian Patients3 5.49% 5.14% 7.35%
American Indian/Alaska Native Patients3 0.30% 1.43% 1.47%
Native Hawaiian/Other Pacific Islander Patients3 0.91% 0.86% 0.00%
Patients with More than one race3 3.96% 3.14% 4.41%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.54% 14.57% 1.47%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.66% 2.29% 1.47%
Unreported/Refused to Report Race and Ethnicity 2.74% 0.00% 1.47%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 23.08%
1 to 24 Hours 30.77%
More Than 24 Hours 30.77%
N/A 15.38%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 38.46%
Vaccine confidence 23.08%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 30.77%
None 23.08%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 38.46%
Average Percent of Health Center Visits Conducted Virtually 20.77%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 23.08%
Number of Mobile Van Sites 1
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 5

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 76.92%
None 23.08%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.69%
Patient awareness/education 15.38%
Staffing capacity 7.69%
Therapy administration/onsite logistics 7.69%
Other 7.69%
None 76.92%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021